Techno Medica Co.,Ltd. FY2026 Q2 Earnings Report | IR Tracker

Techno Medica Co.,Ltd. FY2026 Q2 Earnings Report | IR Tracker

Financial Highlights

Net Sales: ¥4.10B
Operating Income: ¥266M
Net Income: ¥203M
EPS: ¥29.31

Income Statement

Item	Current	Prior	YoY %
Net Sales	¥4.10B	¥4.12B	-0.3%
Cost of Sales	¥2.15B	¥2.04B	+5.4%
Gross Profit	¥1.96B	¥2.08B	-5.9%
SG&A Expenses	¥1.69B	¥1.77B	-4.7%
Operating Income	¥266M	¥304M	-12.5%
Non-operating Income	¥35M	¥7M	+422.5%
Non-operating Expenses	¥7M	¥13M	-45.4%
Ordinary Income	¥294M	¥298M	-1.3%
Profit Before Tax	¥294M	¥299M	-1.4%
Income Tax Expense	¥91M	¥77M	+18.9%
Net Income	¥203M	¥221M	-8.1%
Depreciation & Amortization	¥47M	¥49M	-3.4%
Basic EPS	¥29.31	¥32.06	-8.6%
Dividend Per Share	¥0.00	¥0.00	-

Balance Sheet

Item	Current End	Prior End	Change
Current Assets	¥14.36B	¥15.68B	¥-1.32B
Cash and Deposits	¥8.81B	¥9.06B	¥-253M
Accounts Receivable	¥2.01B	¥3.28B	¥-1.27B
Inventories	¥2.51B	¥2.18B	+¥325M
Non-current Assets	¥2.20B	¥2.26B	¥-58M

Cash Flow Statement

Item	Current	Prior	Change
Operating Cash Flow	¥270M	¥1.43B	¥-1.16B
Investing Cash Flow	¥-52M	¥-9M	¥-43M
Financing Cash Flow	¥-471M	¥-470M	¥-996,000
Free Cash Flow	¥217M	-	-

Profitability Ratios

Item	Value
Net Profit Margin	4.9%
Gross Profit Margin	47.7%
Current Ratio	673.8%
Quick Ratio	556.2%
Debt-to-Equity Ratio	0.17x
EBITDA Margin	7.6%
Effective Tax Rate	31.0%

Year-over-Year Comparison

Item	YoY Change
Net Sales YoY Change	-0.3%
Operating Income YoY Change	-12.6%
Ordinary Income YoY Change	-1.4%
Net Income YoY Change	-8.4%

Item	Value
Shares Outstanding (incl. Treasury)	8.76M shares
Treasury Stock	1.82M shares
Average Shares Outstanding	6.93M shares
Book Value Per Share	¥2,039.90
EBITDA	¥313M

Dividend Information

Item	Amount
Q2 Dividend	¥0.00
Year-End Dividend	¥68.00

Full Year Forecast

Item	Forecast
Net Sales Forecast	¥10.60B
Operating Income Forecast	¥1.48B
Ordinary Income Forecast	¥1.48B
Net Income Forecast	¥1.10B
Basic EPS Forecast	¥158.86
Dividend Per Share Forecast	¥68.00